Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review

EAST HANOVER, N.J.Feb. 11, 2020 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) New Drug Application (NDA). Capmatinib is a MET inhibitor being evaluated as a treatment for first-line and previously treated patients with locally advanced or metastatic MET exon 14 skipping (METex14) mutated non-small cell lung cancer (NSCLC). If approved, capmatinib will be the first therapy to specifically target METex14 mutated advanced lung cancer, a type of lung cancer with a particularly poor prognosis2,3. Continue reading

SEC Uses Data Analysis to Detect Cherry-Picking Fraud By Broker

The Securities and Exchange Commission (SEC) today charged a New Jersey based broker with misusing his access to customers’ brokerage accounts to enrich himself and family members at the expense of his customers, many of whom had entrusted him with their retirement accounts. The SEC uncovered the alleged fraud with data analysis used to detect suspicious trading patterns.

The SEC filed fraud charges in federal district court against Michael A. Bressman of Montville, New Jersey, alleging that he misused his access to an omnibus or “allocation” account to obtain at least $700,000 in illicit trading profits over a six-year period ending in February. The SEC’s complaint alleges that Bressman placed trades using the allocation account and cherry-picked profitable trades, which he then transferred to his own account and the account of two family members, while placing unprofitable trades in other customers’ accounts. Continue reading

George J. Majsiak CPA in Wallington, NJ

Majsiak, CPA is committed to improving client net worth by providing comprehensive tax management, effective accounting solutions, and general business counsel. I fully understand and embrace my responsibility to all individuals and businesses I serve. Majsiak, CPA is customer satisfaction driven.
Majsiak Background
I am a licensed Certified Public Accountant in the State of New Jersey. I obtained an undergraduate business degree, BS, from Niagara University and two advanced business degrees- an MBA in Finance from Fairleigh Dickinson University and an MS in Taxation from Seton Hall University. Currently I am a member of the American Institute of Certified Public Accountants (AICPA) and the New Jersey Society of Certified Public Accountants (NJSPCA).
I have spent over 20 years working for some of the largest Military Defense Companies in the US- ITT, Lear Siegler, Allied Signal, and Lockheed Martin. At these companies I had a very successful career by holding progressively senior financial positions. Nine years at Allied Signal, I was responsible for the profitability of a $150M business segment, which designed and manufactured state-of-the-art cockpit displays for military aircraft. At Lockheed Martin, I was responsible for the profitability of a $200M Information Technology program. In these senior positions, I had purview over all financial aspects, which included cash flow, budgeting, accounts payable, accounts receivable, inventories, strategic plans, financial statement preparation and also Information Systems.
From my tenure at the mentioned companies I bring to my practice strong experience which coupled ith
my education is providing my clients a distinct advantage.
Address:
177 Paterson Avenue
Wallington, New Jersey 07057
Email: george@majsiak.com
PH: 973-777-2333
FX: 201-896-9785
Website: http://majsiak.com
Newsletter:
http://majsiak.com/newsletter.cfm